Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Modern Rheumatology
Published in: Modern Rheumatology 6/2007

01-12-2007 | ORIGINAL ARTICLE

Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial

Authors: Shingo Nakayamada, Kazuyoshi Saito, Hisanori Umehara, Noriyoshi Ogawa, Takayuki Sumida, Satoshi Ito, Seiji Minota, Hiroyuki Nara, Hirobumi Kondo, Jun Okada, Tsuneyo Mimori, Hajime Yoshifuji, Hajime Sano, Naoaki Hashimoto, Susumu Sugai, Yoshiya Tanaka

Published in: Modern Rheumatology | Issue 6/2007

Login to get access
Metadata
Title
Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial
Authors
Shingo Nakayamada
Kazuyoshi Saito
Hisanori Umehara
Noriyoshi Ogawa
Takayuki Sumida
Satoshi Ito
Seiji Minota
Hiroyuki Nara
Hirobumi Kondo
Jun Okada
Tsuneyo Mimori
Hajime Yoshifuji
Hajime Sano
Naoaki Hashimoto
Susumu Sugai
Yoshiya Tanaka
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Modern Rheumatology / Issue 6/2007
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-007-0627-2

Other articles of this Issue 6/2007

Modern Rheumatology 6/2007 Go to the issue

ORIGINAL ARTICLE

Risk factors for total knee arthroplasty in rheumatoid arthritis

ORIGINAL ARTICLE

Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis

Erratum

Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia

CASE REPORT

A case of Wegener's granulomatosis associated with progressive dysphagia owing to esophageal involvement

CASE REPORT

Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis

REVIEW ARTICLE

Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits